RecruitingPhase 3NCT05125302
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Sponsor: AbbVie
Mequon, WI · +124 more sites
2 recruiting migraine studies with a site in Mequon, WI.
Sponsor: AbbVie
Mequon, WI · +124 more sites
Sponsor: AbbVie
Mequon, WI · +15 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.